Literature DB >> 6696724

A liquid-phase two-site immunoradiometric assay for human prolactin.

S C Hodgkinson, J Landon, P J Lowry.   

Abstract

The development of a 'two-site' immunoradiometric assay for human prolactin (hPrl) is described. The assay is based on the addition of radio-iodinated sheep anti-hPrl immunoglobulin G (IgG) and rabbit anti-hPrl serum to standards and unknowns followed by 3 h incubation. The use of solid phase reagents was avoided in order to minimize non-specific effects and the time required for reactants to reach equilibrium. Instead, the separation of hPrl-bound and free labelled antibody is achieved by the addition of sheep anti-(rabbit IgG) serum which precipitates bound labelled antibody by complex formation with rabbit anti-hPrl antibodies which are also hPrl-bound. Varying the order of addition of specific antibodies had a pronounced effect on the 'operating range' and sensitivity of resultant assays. This was attributed to competition between labelled and unlabelled antibodies for binding sites on the hPrl molecule. The immunoradiometric assay employing 'simultaneous addition' of specific antibodies was compared to a 'simultaneous addition' hPrl radioimmunoassay developed using the same sheep antiserum as that used to prepare the radioiodinated sheep anti-hPrl IgG. This immunoradiometric assay is characterized by rapid equilibration of reactants, a wide 'operating range' (the precision of dose estimates was less than 10% over the range 8-10000 mU/l), and high sensitivity (2.6 mU/l, 13 pg). In contrast, the hPrl radioimmunoassay required an incubation of 18 h, demonstrated a much reduced 'operating range' (the precision of dose estimates was less than 10% only over the range 25-1500 mU/l) and reduced sensitivity (9.8 mU/l, 49 pg).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6696724      PMCID: PMC1153206          DOI: 10.1042/bj2170273

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  11 in total

1.  Immunoassay of endogenous plasma insulin in man.

Authors:  R S YALOW; S A BERSON
Journal:  J Clin Invest       Date:  1960-07       Impact factor: 14.808

2.  Observations on the use of solid-phase-coupled antibodies in the radioimmunoassay of human placental lactogen.

Authors:  J Gardner; G Bailey; T Chard
Journal:  Biochem J       Date:  1974-03       Impact factor: 3.857

3.  Measurement of serum ferritin by a 2-site immunoradiometric assay.

Authors:  L E Miles; D A Lipschitz; C P Bieber; J D Cook
Journal:  Anal Biochem       Date:  1974-09       Impact factor: 3.365

4.  Radioimmunoassay and saturation analysis. The immunoradiometric assay and related techniques.

Authors:  J S Woodhead; G M Addison; C N Hales
Journal:  Br Med Bull       Date:  1974-01       Impact factor: 4.291

5.  Report of the National Pituitary Agency. Collaborative study of the radioimmunoassay of human prolactin.

Authors:  M L Aubert; R L Becker; B B Saxena; S Raiti
Journal:  J Clin Endocrinol Metab       Date:  1974-06       Impact factor: 5.958

6.  A homologous radioimmunoassay for human prolactin.

Authors:  Y N Sinha; F W Selby; U J Lewis; W P VanderLaan
Journal:  J Clin Endocrinol Metab       Date:  1973-03       Impact factor: 5.958

7.  Labelled antibodies and immunological assay systems.

Authors:  L E Miles; C N Hales
Journal:  Nature       Date:  1968-07-13       Impact factor: 49.962

8.  Immunoradiometric versus radioimmunoassay: a comparison using alpha-fetoprotein as the model analyte.

Authors:  W M Hunter; P S Budd
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

9.  Selective elution of immunoadsorbed anti-(human prolactin) immunoglobulins with enhanced immunochemical properties.

Authors:  S C Hodgkinson; P J Lowry
Journal:  Biochem J       Date:  1982-09-01       Impact factor: 3.857

10.  Hydrophobic-interaction chromatography and anion-exchange chromatography in the presence of acetonitrile. A two-step purification method for human prolactin.

Authors:  S C Hodgkinson; P J Lowry
Journal:  Biochem J       Date:  1981-12-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.